University of Alabama at Birmingham - Phase I Clinical Trials Unit — Birmingham, Alabama

University of Alabama at Birmingham - Phase I Clinical Trials Unit is a clinical research site located in Birmingham, Alabama, United States 35249.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham - Phase I Clinical Trials Unit has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma, Glioma, Thyroid Cancer.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

• University of Alabama Birmingham - Main & Highlands
• University of Alabama Birmingham Lung Health Center
• University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic
• The University Of Alabama Of Birmingham
• University of Alabama at Birmingham, School of Optometry, Clinical Eye Research Facility
• University of Alabama at Birmingham - School of Medicine-Cardiology ( Site 0153)
• University of Alabama Hospitals
• UAB Hospital /ID# 262565
• University of Alabama at Birmingham Women & Infants Center
• University of Alabama at Birmingham (UAB) - Center for Education & Research on Therapeutics of Musculoskeletal Disorders
• University of Alabama at Birmingham Endocrinology Department
• University of Alabama-The Kirklin Clinic

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham - Phase I Clinical Trials Unit?

University of Alabama at Birmingham - Phase I Clinical Trials Unit has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham - Phase I Clinical Trials Unit conducted?

University of Alabama at Birmingham - Phase I Clinical Trials Unit has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma, Glioma, Thyroid Cancer.

Is University of Alabama at Birmingham - Phase I Clinical Trials Unit accredited by Crixeo Clinical Trials?

University of Alabama at Birmingham - Phase I Clinical Trials Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham - Phase I Clinical Trials Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.